Literature DB >> 28655810

Antithymocyte globulin and transplants for aplastic anemia.

Andrea Bacigalupo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28655810      PMCID： PMC5566012          DOI： 10.3324/haematol.2017.171538

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia.

Authors:  Judith C Marsh; Vikas Gupta; Ziyi Lim; Aloysius Y Ho; Robin M Ireland; Janet Hayden; Victoria Potter; Mickey B Koh; M Serajul Islam; Nigel Russell; David I Marks; Ghulam J Mufti; Antonio Pagliuca
Journal:  Blood       Date:  2011-04-25       Impact factor: 22.113

2.  Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups.

Authors:  Andrea Bacigalupo; Gérard Socié; Hubert Schrezenmeier; Andre Tichelli; Anna Locasciulli; Monika Fuehrer; Antonio M Risitano; Carlo Dufour; Jakob R Passweg; Rosi Oneto; Mahmoud Aljurf; Catherine Flynn; Valerie Mialou; Rose Marie Hamladji; Judith C W Marsh
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

3.  Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro.

Authors:  Xingmin Feng; Sachiko Kajigaya; Elena E Solomou; Keyvan Keyvanfar; Xiuli Xu; Nalini Raghavachari; Peter J Munson; Thomas M Herndon; Jichun Chen; Neal S Young
Journal:  Blood       Date:  2008-02-04       Impact factor: 22.113

4.  Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens.

Authors:  Richard E Champlin; Waleska S Perez; Jakob R Passweg; John P Klein; Bruce M Camitta; Eliane Gluckman; Christopher N Bredeson; Mary Eapen; Mary M Horowitz
Journal:  Blood       Date:  2007-02-01       Impact factor: 22.113

5.  A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells.

Authors:  Marta Lopez; Michael R Clarkson; Monica Albin; Mohamed H Sayegh; Nader Najafian
Journal:  J Am Soc Nephrol       Date:  2006-08-16       Impact factor: 10.121

6.  Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia.

Authors:  Phillip Scheinberg; Steven H Fischer; Li Li; Olga Nunez; Colin O Wu; Elaine M Sloand; Jeffrey I Cohen; Neal S Young; A John Barrett
Journal:  Blood       Date:  2006-12-05       Impact factor: 22.113

7.  Allogeneic marrow grafting for treatment of aplastic anemia.

Authors:  R Storb; E D Thomas; C D Buckner; R A Clift; F L Johnson; A Fefer; H Glucksberg; E R Giblett; K G Lerner; P Neiman
Journal:  Blood       Date:  1974-02       Impact factor: 22.113

Review 8.  Standard treatment of acquired SAA in adult patients 18-40 years old with an HLA-identical sibling donor.

Authors:  M Aljurf; H Al-Zahrani; M T Van Lint; J R Passweg
Journal:  Bone Marrow Transplant       Date:  2012-11-19       Impact factor: 5.483

9.  Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation.

Authors:  H J Deeg; I D Amylon; R E Harris; R Collins; P G Beatty; S Feig; N Ramsay; M Territo; S P Khan; D Pamphilon; J F Leis; S Burdach; C Anasetti; R Hackman; B Storer; B Mueller
Journal:  Biol Blood Marrow Transplant       Date:  2001       Impact factor: 5.742

10.  Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis.

Authors:  Andrea Bacigalupo; Gerard Socié; Rose Marie Hamladji; Mahmoud Aljurf; Alexei Maschan; Slawomira Kyrcz-Krzemien; Alicja Cybicka; Henrik Sengelov; Ali Unal; Dietrich Beelen; Anna Locasciulli; Carlo Dufour; Jakob R Passweg; Rosi Oneto; Alessio Signori; Judith C W Marsh
Journal:  Haematologica       Date:  2015-01-23       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.